Democratizing hedge fund level analysis tools for everyone
| Name | Brigit Biofarmaka Teknologi Tbk. |
| Sector | Healthcare |
| Industry | Pharmaceuticals & Health Care Research |
| Code | F2 |
| Latest Quarterly | 06-30-25 |
| Name | Latest % | A Month Ago % |
|---|---|---|
| Machmud Lutfi Huzain | 31.6 | 34.24 |
| Amei Lisa Dita Karina | 28.44 | 30.82 |
| Public < 5% | 24.42 | 18.22 |
| Drs. Surono Subekti | 12.38 | 13.3 |
| Narno Raharjo | 3.16 | 3.42 |
| Source | 2022 | 2021 |
|---|
| Region | 2022 | 2021 |
|---|
| Valuation | Ratio | Rank |
|---|---|---|
| P/S | 1.65 | # 11 / 15 |
| EV_EBITDA | 5.14 | # 1 / 15 |
| PER | 8.30 | # 3 / 15 |
| PBV | 1.89 | # 8 / 15 |
| DER | 0.20 | # 3 / 15 |
| Profitability | Ratio | Rank |
|---|---|---|
| NPM % | 17.5817 | # 2 / 15 |
| ROA % | 19.6 | # 2 / 15 |
| ROE % | 22.470000000000002 | # 2 / 15 |
| Year | DPS | Yield [%] |
|---|---|---|
| 2025 | 22.37 | 5.8 |
| Timeframe | Performance |
|---|---|
| 1W % | -1.1 |
| 1Mo % | -8.8 |
| 3Mo % | -14.3 |
| 1Yr % | -50.5 |
| Stocks | PER | Market Cap | EV | Revenue | EBITDA | Net Profit |
|---|---|---|---|---|---|---|
| KLBF | 14.94 | 52.43 T | 53.67 T | 34,651 B | 5,348 B | 3,508 B |
| SOHO | 57.58 | 33.76 T | 36.00 T | 10,566 B | 742 B | 587 B |
| SIDO | 14.43 | 15.75 T | 15.31 T | 3,639 B | 1,481 B | 1,091 B |
| TSPC | 8.35 | 12.67 T | 11.15 T | 13,512 B | 2,016 B | 1,515 B |
| PYFA | -9.55 | 4.67 T | 10.70 T | 2,747 B | -142 B | -488 B |
| MDLA | 8.92 | 3.45 T | 6.04 T | 14,788 B | 557 B | 386 B |